HALOZYME THERAPEUTICS, INC. (HALO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading HALO…

HALOZYME THERAPEUTICS, INC. (HALO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

HALOZYME THERAPEUTICS, INC.

HALO · CIK 1159036

4 · Oct 2, 2026 · Director Posard Matthew L. sold 5,230 shares at $108.54/share ($567.7K)

4

Director Posard Matthew L. sold 5,230 shares at $108.54/share ($567.7K)

Filed: Oct 2, 2026
Period: Oct 1, 2026
Accession: 0001159036-26-000133
Filer: HALOZYME THERAPEUTICS, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790973495.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790973495.xml
Open SEC.gov